To include your compound in the COVID-19 Resource Center, submit it here.

NCCN reaffirms Avastin recommendation

The National Comprehensive Cancer Network (NCCN) reaffirmed its recommendation for Avastin bevacizumab as an option for

Read the full 169 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE